本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或者治疗，非药用，非食用。
Amberlite® IRP-69阳离子交换树脂
英文名：Amberlite® IRP-69
Cas号：55464-99-8
Cas号：55464-99-8
检测信息查询
| 别 名 | |
| Cas号 | 55464-99-8 |
| M D L | MFCD00132786 |
| 分子式 | |
| 分子量 | 380 |
| 产品参数 | 外观Appearance 粉末
水分Water <含量≥ 35-55（％） % (K.F.) 钠含量Assay other 9.4 - 11.5 % (Na) 氨盐ammonium salts: 合格 钾交换容量potassium exchange capacity: 110 - 135 mg/g 粒径分析particle size analysis: 100目过筛screens on 100 mesh: < 1% 200目过筛screens on 200 mesh: 10.0 - 25.0% |
| 性状 | 不溶于水。
Amberlite irp69树脂是一种不溶性，强酸性，钠的形式作为一个干提供的阳离子交换树脂，细粉或颗粒。Amberlite irp69树脂适用于药物的应用，无论是作为一种活性成分，为载体的基础（阳离子）的药物。它可用于持续释放应用程序兼容的涂层技术。 质量标准 AMBERLITE IRP69 Pharmaceutical Grade Cation Exchange Resin (Sodium Polystyrene Sulfonate USP) Description AMBERLITE IRP69 resin is an insoluble, strongly acidic, sodium form cation exchange resin supplied as a dry, fine powder. AMBERLITE IRP69 resin is suitable for use in pharmaceutical applications, both as an active ingredient and as a carrier for basic (cationic) drugs. It can be used for sustained release applications with compatible coating technologies. Regulatory Status A Drug Master File for AMBERLITE IRP69 resin is maintained with the United States Food and Drug Administration. Letters of authorization granting access to the file by FDA in support of NDA and ANDA submittals will be provided IRP69 in many other countries world-wide. AMBERLITE IRP69 resin is manufactured in accordance with Good Manufacturing Practices (cGMP) for bulk pharmaceutical chemicals. 储存条件 常温密封避光保存，Stored in cool, dry and airproof. |
| 贮存 |
- Amberlite XAD-16 非离子型大孔树脂 104219-63-8
- Amberlite XAD-1180N 非离子型多孔树脂 97396-56-0
- Amberlyst® A21 大孔树脂 9049-93-8
- Amberlite® IRC-748螯合型离子交换树脂 79620-28-3
- Amberlite® IRP-69阳离子交换树脂 55464-99-8
- 2,3-环戊烯并吡啶 533-37-9
- 2-甲基-4-硝基氧化吡啶 5470-66-6
- 6-氯-3-甲基尿嘧啶 4318-56-3
沪公网安备 31012002003054号